Items where Author is "Çapkın, Eda"

Article

Çapkın, Eda and Kutlu, Aslı and Yüce, Meral (2023) Repurposing Fc gamma receptor I (FcγRI, CD64) for site-oriented monoclonal antibody capture: a proof-of-concept study for real-time detection of tumor necrosis factor-alpha (TNF -α). Heliyon, 9 (9). ISSN 2405-8440

Kulabhusan, Prabir Kumar and Pishva, Parsa and Çapkın, Eda and Tambe, Prajakta and Yüce, Meral (2023) Aptamer-based emerging tools for viral biomarker detection: a focus on SARS-CoV-2. Current Medicinal Chemistry, 30 (8). pp. 910-934. ISSN 0929-8673 (Print) 1875-533X (Online)

Çapkın, Eda and Kurt, Hasan and Gürel, Büşra and Bıçak, Dilan and Akgün Bas, Sibel and Dağlıkoca, Duygu Emine and Yüce, Meral (2022) Characterization of FcγRIa (CD64) as a ligand molecule for site-specific IgG1 capture: a side-by-side comparison with protein A. Langmuir, 38 (48). pp. 14623-14634. ISSN 0743-7463 (Print) 1520-5827 (Online)

Gürel, Büşra and Berksoz, Melike and Çapkın, Eda and Parlar, Ayhan and Pala, Meltem Çorbacıoğlu and Özkan, Aylin and Capan, Yılmaz and Dağlıkoca, Duygu Emine and Yüce, Meral (2022) Structural and functional analysis of CEX fractions collected from a novel avastin® biosimilar candidate and its innovator: a comparative study. Pharmaceutics, 14 (8). ISSN 1999-4923

Gürel, Büşra and Çapkın, Eda and Parlar, Ayhan and Özkan, Aylin and Çorbacıoğlu, Meltem and Dağlikoca, Duygu Emine and Yüce, Meral (2022) Optimized methods for analytical and functional comparison of biosimilar mAb drugs: a case study for Avastin, Mvasi, and Zirabev. Scientia Pharmaceutica, 90 (2). ISSN 0036-8709 (Print) 2218-0532 (Online)

Thesis

Çapkın, Eda (2023) Revealing the Analytical Potential of FcγRIa (CD64) as a Ligand Molecule for IgG1 Capture and Antigen Sensing: Evaluation of FcγRIa ectodomain via Molecular Dynamics. [Thesis]